Dr. Xing Wang is a Bioengineering professor, affiliated with the Chemistry Department, Carl R. Woese Institute for Genomic Biology (IGB), Holonyak Micro and Nanotechnology Laboratory (HMNTL), and Cancer Center at Illinois (CCIL) at the University of Illinois Urbana-Champaign (UIUC).  He received a Ph.D. from New York University, working with Dr. Ned Seeman to build biofunctional DNA motifs.  He did his postdoc training at Princeton University with a focus on nucleic acid engineering and RNA biology.  At UIUC, Dr. Wang directs the Nucleic Acids Programming Lab (NAPL), and his research group utilizes nucleic acid and protein engineering to evolve new molecular ligands for targeted drug delivery and create designer DNA nanostructure-based “plug-and-play” platforms for the applications in disease diagnosis and treatment.  Dr. Wang is a recipient of Mikashi Award in 2021.  He was selected as a Fellow of Y Combinator Founder Cohort in 2021.  He received a Spoke Award in 2024.  Dr. Wang’s research group is mainly supported by the National Institutes of Health (NIH) and National Science Foundation (NSF).